---
layout: post
title: "Collaboration Opportunity To Develop a Vaccine Against Nicotine or Arecoline"
date: 2026-02-05 18:56:30 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-17672
original_published: 2023-08-17 00:00:00 +0000
significance: 8.00
---

# Collaboration Opportunity To Develop a Vaccine Against Nicotine or Arecoline

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** August 17, 2023 00:00 UTC
**Document Number:** 2023-17672

## Summary

The Cancer Prevention Program of the National Cancer Institute (NCI) is seeking a partner in the private sector to develop a vaccine directed against nicotine or a related molecule called arecoline, with the goal of reducing or eliminating the craving of such substance(s) in smokers or betel nut users.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/08/17/2023-17672/collaboration-opportunity-to-develop-a-vaccine-against-nicotine-or-arecoline)
- API: https://www.federalregister.gov/api/v1/documents/2023-17672

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
